Infectious Disease Guidelines launched across Pakistan
Pfizer supports the initiative by Medical Microbiology & Infectious Diseases Society of Pakistan (MMIDSP)
Pfizer Pakistan Limited, 11 September, 2015: In various events held in Karachi, Lahore and Islamabad – medical guidelines on management of infectious diseases (IDs) were launched in the presence of leading healthcare professionals and medical society representatives. The guidelines are a commendable initiative by Medical Microbiology and Infectious Diseases Society of Pakistan (MMIDSP) as resistance has started to develop across the world especially in the developing countries where antibiotics are often liberally prescribed. WHO has started a global effort to address this problem and issued a report last year, "Antimicrobial resistance: global report on surveillance", which notes that resistance is occurring across many different infectious agents.
Antibiotics are highly effective and can save lives by helping patients fight various infections. However, improper use of antibiotics is also widespread which reduces their efficacy to cure the infection. The main emphasis of the event was on the concept of Antibiotic Stewardship – which promotes the appropriate use of antibiotics needed to improve patient outcomes and decrease spread of communicable diseases.
Pfizer is committed to advancing wellness, treatments and cures for people with various health issues. The roll out of these guidelines and advocating the concept of Antibiotic Stewardship is a vital part of this commitment. Dr. Asghar Naqvi, Medical Director for Pfizer in Pakistan said, “Pfizer’s role is to work with healthcare professionals, enhance medical knowledge and bring the top minds in the field of medicine together to work on projects that positively impact overall health in Pakistan. We are thankful to the MMIDSP for putting together these guidelines which will help physicians in their treatment of infectious diseases.”
The launch kicked off in Karachi with a Continuing Medical Education (CME) session hosted by Pfizer and duly accredited by the College of Family Medicine, Pakistan where infectious disease experts gave presentations covering emergence of bacterial resistance, and management of uncomplicated viral respiratory infections with simple home remedies. Dr. Naseem Salahuddin, Adult Infectious Diseases Specialist at The Indus Hospital stressed upon the importance of rising drug resistance against once easily treatable infections. “Antibiotics have transformed the practice of medicine, making once lethal infections readily treatable. The prompt initiation of antibiotics to treat infections has been proven to reduce morbidity and save lives; however, their improper and unnecessary use leads to not only adverse effects, but also the emergence of antibiotic resistance, thus making many infections untreatable." She emphasized upon doctors to spend more time listening to patients, rather than writing hurried prescriptions.
Dr. Faisal Mahmood, Adult Infectious Diseases Specialist associated with the Aga Khan University Hospital (AKUH) kept the audience engaged with a number of case-based scenarios to create awareness regarding the right choice of antibiotics in different infections. Other speakers included ID Specialists, Dr. Samreen Sarfaraz and Dr. Fatima Mir as well as Clinical Microbiologists Dr. Altaf Ahmed and Dr. Javeria Farooqui.
Pfizer Pakistan: Working together for a healthier world™
Pfizer has been working for the health and wellbeing of patients in Pakistan for more than 50 years. Our business in Pakistan is part of the global Pfizer Inc. operations, first founded in 1849 in New York, USA. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our operations in Pakistan, please visit us at www.pfizer.com.pk